- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Non-invasive measurement of tumor blood flow with 82Rubidium PET in prostate cancer
2020.12.03 |
| Date | Thu 17 Dec |
| Time | 14:00 — 16:00 |
| Location | Store Anatomisk Auditorium, building 1232, room 115, Aarhus University, Wilhelm Meyers Allé 3, 8000 Aarhus C and online via Zoom |
Thursday 17 December at 14:00, Mads Ryø Jochumsen defends his PhD dissertation entitled "Non-invasive measurement of tumor blood flow with 82Rubidium PET in prostate cancer".
Prostate cancer is one of the most common malignancies in men, ranging from indolent low-risk disease to very aggressive cancer. Consequently, an important challenge in prostate cancer management is to differentiate clinically significant prostate cancer, which require active treatment, from insignificant disease. Tumor blood flow is essential for tumor growth. Therefore, a new ph.d.-project from Aarhus University, Health studied the non-invasive 82Rubidium positron emission tomography (PET) scan for tumor blood flow measurement in prostate cancer. Furthermore, the clinical usefulness of tumor blood flow for risk-evaluation as well as the underlying tumor biology were studied. With non-invasive measures of both prostate-specific membrane antigen (PSMA) uptake and tumor blood flow with PET, we could correctly classify most lesions into significant or insignificant prostate cancer and thereby provide clinically relevant information about prostate cancer aggressiveness.
The summary is written by the PhD student.
The defence is public and will be held in Store Anatomisk Auditorium, building 1232, room 115, Aarhus University, Wilhelm Meyers Allé 3, 8000 Aarhus C and online via Zoom (Meeting ID: 671 2804 7374, link: https://aarhusuniversity.zoom.us/j/67128047374). Please read the attached press release for more information.
PhD student Mads Ryø Jochumsen
Mail: madsjoch@rm.dk
Phone: (+45) 61663110